Cold Exposure Therapy for ALS
Also known as: Cold water immersion, Cryotherapy, Cold plunge, Wim Hof method
Cold shock proteins (RBM3, CIRP) may protect motor neurons from protein aggregation-driven degeneration.
Mechanism of Action
Cold exposure induces RBM3 and CIRP, which stabilize mRNA translation and may prevent protein aggregation in motor neurons. Norepinephrine release reduces neuroinflammation. Metabolic hormesis enhances cellular stress resilience.
General mechanism: Hormetic cold stress. RBM3/CIRP cold shock proteins, norepinephrine release, NK cell activation, BAT activation, anti-inflammatory.
Current Evidence
RBM3 neuroprotection mechanism established. ALS-specific cold exposure data is absent. Safety considerations for patients with bulbar involvement.
Clinical Status: Preclinical rationale from RBM3 research. Safety evaluation needed for ALS.
Safety Profile
Generally safe with gradual adaptation. Cardiac arrhythmia risk in cold water. Contraindicated in Raynaud's, unstable cardiac disease. Supervision recommended for neurological patients.
Key Research Questions
- Can cold shock proteins prevent TDP-43/SOD1 aggregation in motor neurons?
- Is cold exposure safe for ALS patients with respiratory compromise?